A Trial Investigating the Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec/Insulin Aspart 15 in Subjects With Type 1 Diabetes
Clinical trial NCT01773798 · COMPLETED
Trial details
- NCT number
- NCT01773798
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2013-08-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.